Europe — EMA
Eloquine (Mefloquine)
Eloquine is an antimalarial medication containing mefloquine, used to prevent and treat malaria. This oral medication is manufactured by Medochemie Ltd. in the
Request sourcing
What is Mefloquine?
Eloquine is an antimalarial medication containing mefloquine, used to prevent and treat malaria. This oral medication is manufactured by Medochemie Ltd. in the EU.
What is Mefloquine used for?
Eloquine is primarily used for the prevention and treatment of malaria, a disease caused by parasites transmitted through mosquito bites. It is often prescribed for travelers to areas where malaria is prevalent. The active ingredient, mefloquine, works by interfering with the growth of the parasites in the red blood cells.
What are the side effects of Mefloquine?
Common effects of Eloquine may include stomach pain, diarrhea, and dizziness. Some users might experience vivid dreams or nightmares. These effects vary among individuals and are not experienced by everyone who takes the medication.
What precautions apply to Mefloquine?
Eloquine should be used with caution, especially by individuals with a history of seizures, psychiatric disorders, or heart conditions. It is important to follow the prescribed dosage and consult a healthcare provider before starting the medication. Pregnant women and those planning to become pregnant should discuss the risks and benefits with their doctor.
What does Mefloquine interact with?
Eloquine may interact with other medications, including those that affect the central nervous system, such as antidepressants and antipsychotics. It is also important to avoid alcohol while taking Eloquine, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.



